Global Peripheral Vascular Stents Market 2017-2021

末梢血管ステントの世界市場2017-2021:自己拡張型、バルーン拡張型、薬剤溶出型

◆タイトル:Global Peripheral Vascular Stents Market 2017-2021
◆商品コード:IRTNTR14621
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年9月5日
◆ページ数:109
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:Healthcare and Life Sciences
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、末梢血管ステントの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、末梢血管ステントの世界市場規模及び予測、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は末梢血管ステントの世界市場が2017-2021年期間中に年平均7.96%成長すると予測しています。当レポート上に記載されている主な企業はBoston Scientific、Abbott、Medtronic、Cook、C. R. Bard、BIOTRONIK、Cordis (a Cardinal Health company)等です。

・エグゼクティブサマリー
・末梢血管ステントの世界市場:市場概観
・末梢血管ステントの世界市場:業界の構造分析
・末梢血管ステントの世界市場:市場規模及び予測
・末梢血管ステントの世界市場:製品別分析
・末梢血管ステントの世界市場:需要先別分析
・末梢血管ステントの世界市場:地域別分析
・末梢血管ステントの世界市場:アジア市場規模
・末梢血管ステントの世界市場:アメリカ市場規模
・末梢血管ステントの世界市場:ヨーロッパ市場規模
・末梢血管ステントの世界市場:成長要因
・末梢血管ステントの世界市場:課題
・末梢血管ステントの世界市場:市場動向
・末梢血管ステントの世界市場:競争状況
・末梢血管ステントの世界市場:主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Peripheral Vascular Stents
Peripheral vascular stents are most commonly used in treating conditions called as PVDs. It is crampy leg pain that occurs during walking and exercise. It occurs in individuals aged 65 and above and is the result of atherosclerosis (hardening of the arteries), which occurs due to scar tissue and cholesterol build up, forming a substance called plaque inside the arteries.

Technavio’s analysts forecast the global peripheral vascular stents market to grow at a CAGR of 7.96% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global peripheral vascular stents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Peripheral Vascular Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Boston Scientific
• Abbott
• Medtronic
• Cook
• C. R. Bard
• BIOTRONIK
• Cordis (a Cardinal Health company)

[Other prominent vendors]
• 480 Biomedical
• Alvimedica
• B. Braun Melsungen
• Balton
• Bentley
• Biosensors International Group
• ENDOCOR
• eucatech
• InSitu Technologies
• InspireMD
• iVascular
• KYOTO MEDICAL PLANNING
• Meril Life Sciences
• optimed
• PanMed US
• RONTIS
• Terumo Medical
• Veryan Medical
• W. L. Gore & Associates

[Market driver]
• Ubiquity of PAD
• For a full, detailed list, view our report

[Market challenge]
• Risks and complications associated with peripheral vascular stents
• For a full, detailed list, view our report

[Market trend]
• Technology caters the pace for advances in stenting
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research methodology

PART 04: Introduction
• Peripheral vascular stents

PART 05: Market landscape
• Market overview

PART 06: Five forces analysis

PART 07: Market segmentation by product
• Global self-expanding peripheral vascular stents market
• Global balloon-expanding peripheral vascular stents market
• Global drug-eluting peripheral vascular stents market

PART 08: Market segmentation by end-user
• Hospitals
• ASCs
• Cath labs

PART 09: Geographical segmentation
• Peripheral vascular stents market in Americas
• Peripheral vascular stents market in EMEA
• Peripheral vascular stents market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Market challenges

PART 12: Market trends
• Technology caters the pace for advances in stenting
• Emergence of bioabsorbable stents
• New product launches and ongoing clinical trials

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• Boston Scientific
• Abbott
• Medtronic
• Cook
• C. R. Bard
• BIOTRONIK
• Cordis (a Cardinal Health company)
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Share of stents usage in different peripheral arteries 2016 (%)
Exhibit 02: Global peripheral vascular stents market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global peripheral vascular stents market by product
Exhibit 05: Global peripheral vascular stents market by product 2016 and 2021 (%)
Exhibit 06: Global peripheral vascular stents market analysis by product
Exhibit 07: Global peripheral vascular stents market by product 2016 and 2021 ($ millions)
Exhibit 08: Global peripheral vascular stents market by product 2016-2021 ($ millions)
Exhibit 09: Global peripheral vascular stents market by product 2016-2021 (%)
Exhibit 10: Global self-expanding peripheral vascular stents market 2016-2021 ($ millions)
Exhibit 11: Global balloon-expanding peripheral vascular stents market 2016-2021 ($ millions)
Exhibit 12: Global drug-eluting peripheral vascular stents market 2016-2021 ($ millions)
Exhibit 13: Global peripheral vascular stents market by end-users 2016
Exhibit 14: Global peripheral vascular stents market by geography 2016 (%)
Exhibit 15: Global peripheral vascular stents market by geography 2021 (%)
Exhibit 16: Global peripheral vascular stents market by geography 2016 and 2021 (%)
Exhibit 17: Global peripheral vascular stents market by geography 2016 and 2021 ($ millions)
Exhibit 18: Global peripheral vascular stents market analysis by geography 2016
Exhibit 19: Peripheral vascular stents market in Americas 2016-2021 ($ millions)
Exhibit 20: Peripheral vascular stents market in EMEA 2016-2021 ($ millions)
Exhibit 21: Peripheral vascular stents market in APAC 2016-2021 ($ millions)
Exhibit 22: Global peripheral vascular stents market by geography 2016-2021 ($ millions)
Exhibit 23: Global peripheral vascular stents market by geography 2016-2021 (%)
Exhibit 24: New product launches 2015-2016
Exhibit 25: Various active ongoing clinical studies on peripheral vascular stents
Exhibit 26: Competitive structure analysis of global peripheral vascular stents market 2016
Exhibit 27: Market share of vendors in global peripheral vascular stents market 2016
Exhibit 28: Leading vendors ranking in global peripheral vascular stents market 2016
Exhibit 29: Boston Scientific: Key highlights
Exhibit 30: Boston Scientific: Strength assessment
Exhibit 31: Boston Scientific: Strategy assessment
Exhibit 32: Boston Scientific: Opportunity assessment
Exhibit 33: Abbott: Key highlights
Exhibit 34: Abbott: Strength assessment
Exhibit 35: Abbott: Strategy assessment
Exhibit 36: Abbott: Opportunity assessment
Exhibit 37: Medtronic: Key highlights
Exhibit 38: Medtronic: Strength assessment
Exhibit 39: Medtronic: Strategy assessment
Exhibit 40: Medtronic: Opportunity assessment
Exhibit 41: Cook: Key highlights
Exhibit 42: Cook: Strength assessment
Exhibit 43: Cook: Strategy assessment
Exhibit 44: Cook: Opportunity assessment
Exhibit 45: C. R. Bard: Key highlights
Exhibit 46: C. R. Bard: Strength assessment
Exhibit 47: C. R. Bard: Strategy assessment
Exhibit 48: C. R. Bard: Opportunity assessment
Exhibit 49: BIOTRONIK: Key highlights
Exhibit 50: BIOTRONIK: Strength assessment
Exhibit 51: BIOTRONIK: Strategy assessment
Exhibit 52: BIOTRONIK: Opportunity assessment
Exhibit 53: Cordis: Key highlights
Exhibit 54: Cordis: Strength assessment
Exhibit 55: Cordis: Strategy assessment
Exhibit 56: Cordis: Opportunity assessment



【掲載企業】

Boston Scientific, Abbott, Medtronic, Cook, C. R. Bard, BIOTRONIK, Cordis (a Cardinal Health company), 480 Biomedical, Alvimedica, B. Braun Melsungen, Balton, Bentley, Biosensors International Group, ENDOCOR, eucatech, InSitu Technologies, InspireMD, iVascular, KYOTO MEDICAL PLANNING, Meril Life Sciences, optimed, PanMed US, RONTIS, Terumo Medical, Veryan Medical, and W. L. Gore & Associates.


【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[末梢血管ステントの世界市場2017-2021:自己拡張型、バルーン拡張型、薬剤溶出型]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆